887 related articles for article (PubMed ID: 20514902)
1. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E
Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902
[TBL] [Abstract][Full Text] [Related]
2. Elevated vascular endothelial growth factor in systemic sclerosis.
Choi JJ; Min DJ; Cho ML; Min SY; Kim SJ; Lee SS; Park KS; Seo YI; Kim WU; Park SH; Cho CS
J Rheumatol; 2003 Jul; 30(7):1529-33. PubMed ID: 12858453
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of soluble vascular endothelial growth factor receptor-2 in patients with systemic sclerosis.
Jinnin M; Makino T; Kajihara I; Honda N; Makino K; Ogata A; Ihn H
Br J Dermatol; 2010 Apr; 162(4):751-8. PubMed ID: 19886888
[TBL] [Abstract][Full Text] [Related]
4. Elevated matrix metalloproteinase-9 in patients with systemic sclerosis.
Kim WU; Min SY; Cho ML; Hong KH; Shin YJ; Park SH; Cho CS
Arthritis Res Ther; 2005; 7(1):R71-9. PubMed ID: 15642145
[TBL] [Abstract][Full Text] [Related]
5. Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea.
Vuorio T; Kähäri VM; Black C; Vuorio E
J Rheumatol; 1991 Feb; 18(2):247-51. PubMed ID: 2023219
[TBL] [Abstract][Full Text] [Related]
6. Correlation of endostatin and tissue inhibitor of metalloproteinases 2 (TIMP2) serum levels with cardiovascular involvement in systemic sclerosis patients.
Dziankowska-Bartkowiak B; Waszczykowska E; Zalewska A; Sysa-Jedrzejowska A
Mediators Inflamm; 2005 Aug; 2005(3):144-9. PubMed ID: 16106100
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
8. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.
Manetti M; Guiducci S; Romano E; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2012 Jun; 71(6):1064-72. PubMed ID: 22258486
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis in systemic sclerosis: impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions.
Avouac J; Wipff J; Goldman O; Ruiz B; Couraud PO; Chiocchia G; Kahan A; Boileau C; Uzan G; Allanore Y
Arthritis Rheum; 2008 Nov; 58(11):3550-61. PubMed ID: 18975312
[TBL] [Abstract][Full Text] [Related]
10. Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis.
Carrai V; Miniati I; Guiducci S; Capaccioli G; Alterini R; Saccardi R; Conforti ML; Rigacci L; Rotunno G; Bosi A; Cerinic MM
Rheumatology (Oxford); 2012 Jun; 51(6):1042-8. PubMed ID: 22271757
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma.
Tomimura S; Ogawa F; Iwata Y; Komura K; Hara T; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
J Dermatol Sci; 2008 Oct; 52(1):47-54. PubMed ID: 18565735
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of interleukin 8 and autoantibodies to interleukin 8 in the serum of patients with systemic sclerosis and related disorders.
Reitamo S; Remitz A; Varga J; Ceska M; Effenberger F; Jimenez S; Uitto J
Arch Dermatol; 1993 Feb; 129(2):189-93. PubMed ID: 8434976
[TBL] [Abstract][Full Text] [Related]
13. The immunohistochemical analysis of vascular endothelial growth factors A and C and microvessel density in gingival tissues of systemic sclerosis patients: their possible effects on gingival inflammation.
Ozcelik O; Haytac MC; Ergin M; Antmen B; Seydaoglu G
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Apr; 105(4):481-5. PubMed ID: 18206400
[TBL] [Abstract][Full Text] [Related]
14. Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls.
Young-Min SA; Beeton C; Laughton R; Plumpton T; Bartram S; Murphy G; Black C; Cawston TE
Ann Rheum Dis; 2001 Sep; 60(9):846-51. PubMed ID: 11502611
[TBL] [Abstract][Full Text] [Related]
15. The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis.
Davies CA; Jeziorska M; Freemont AJ; Herrick AL
Hum Pathol; 2006 Feb; 37(2):190-7. PubMed ID: 16426919
[TBL] [Abstract][Full Text] [Related]
16. Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis.
Del Papa N; Colombo G; Fracchiolla N; Moronetti LM; Ingegnoli F; Maglione W; Comina DP; Vitali C; Fantini F; Cortelezzi A
Arthritis Rheum; 2004 Apr; 50(4):1296-304. PubMed ID: 15077314
[TBL] [Abstract][Full Text] [Related]
17. Increased circulating concentrations of the counteradhesive proteins SPARC and thrombospondin-1 in systemic sclerosis (scleroderma). Relationship to platelet and endothelial cell activation.
Macko RF; Gelber AC; Young BA; Lowitt MH; White B; Wigley FM; Goldblum SE
J Rheumatol; 2002 Dec; 29(12):2565-70. PubMed ID: 12465153
[TBL] [Abstract][Full Text] [Related]
18. [The effect of matrix metalloproteinase-9 in granulocyte colony stimulation factor-induced stem cell mobilization].
Jin FY; Qiu LG; Li QC; Meng HX; Wang YF; Yu Z; Li Q; Han JL
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2966-70. PubMed ID: 17288807
[TBL] [Abstract][Full Text] [Related]
19. The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer.
Tamura M; Oda M; Matsumoto I; Tsunezuka Y; Kawakami K; Ohta Y; Watanabe G
Ann Surg Oncol; 2004 Oct; 11(10):928-33. PubMed ID: 15383417
[TBL] [Abstract][Full Text] [Related]
20. Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP-12-dependent cleavage of the endothelial cell urokinase receptor.
Serratì S; Cinelli M; Margheri F; Guiducci S; Del Rosso A; Pucci M; Fibbi G; Bazzichi L; Bombardieri S; Matucci-Cerinic M; Del Rosso M
J Pathol; 2006 Oct; 210(2):240-8. PubMed ID: 16917801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
